In contrast, early-onset AD (prior to age 65) is rare but has a stronger genetic component (APP, PSEN1, or PSEN2 variants) and is associated with a more aggressive and often atypical clinical presentation (Mendez, 2017). This evidence concerns the gene PSEN1 and Alzheimer disease.